Statistics
Publications
1
Citations
13
H-Index
1
Active since
2022
Affiliations
Université Laval(Current)
Nassira Belmessabih is an author at Université Laval specializing in cell cycle inhibitors, cell cycle inhibition, and chemotherapy resistance.
Publications per year
2022–2022
1
1
CRIF1-CDK2 Interface Inhibitors Enhance Taxol Inhibition of the Lethal Triple-Negative Breast Cancer
Xiaoye Sang, Nassira Belmessabih, Ruixuan Wang et al. · Cancers · 2022 · 13 citations · Full text
Medicine, Oncology, Pharmacology +17
1–1 of 1